Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Actavis plc operates as an investment holding company.It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.The company was founded on October 1, 2013 and is... 
Sector
Pharmaceuticals
Calendar
02/17Earnings Release
Surperformance© rating of Actavis Inc
Trading Rating : Investor Rating :
More about the company
Financials ($)
Sales 2014 12 643 M
EBIT 2014 3 814 M
Net income 2014 1 213 M
Debt 2014 15 045 M
Yield 2014 -
Sales 2015 15 535 M
EBIT 2015 5 578 M
Net income 2015 2 993 M
Debt 2015 10 196 M
Yield 2015 -
PER 2014 -
PER 2015 23,39
EV / Sales 2014 6,86x
EV / Sales 2015 5,27x
Capitalization 71 649 M
More Financials
Latest news on ACTAVIS INC
1d agoDJCEOS' TEST : Contending With Activist Investors
1d ago ACTAVIS : Stock Updates on Pharma Services - Avanir Pharma, Zoetis, Allergan, Ma..
2d ago ACTAVIS MULLS JOB CUTS, CHINA EXPANS : Bloomberg
5d ago Valeant slashes stake in Allergan after losing bid
5d ago Global M&A lending hits post-crisis high
5d ago Global M&A deals cross $3 trillion for first time since 2007
6d ago Valeant slashes stake in Allergan after losing bid
6d ago Valeant Pharma says may buy back up to $2 billion worth of securities
6d agoDJValeant Sets $2 Billion Buyback Plan After Losing Allergan
7d agoDJFor Allergan Suitors, Unorthodox Alliance Proved Unwieldy
11/18DJGoldman Hits Mother Lode on Deals
11/18DJAckman Drops Push for Allergan Holder Meeting--2nd Update
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF